2020, ' Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia ', Stroke . https://doi.org/10.1161/STROKEAHA.120.029474 Du, H, Wilson, D, Ambler, G, Banerjee, G, Shakeshaft, C, Cohen, H, Yousry, T, Al-Shahi Salman, R, Lip, G Y H, Houlden, H, Brown, M M, Muir, K W, Jäger, H R, Werring, D J & Clinical relevance of Microbleeds in Stroke (CROMIS-2) collaborators 2021, ' Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia ', Stroke, vol. 52, no. 1, pp. 91-99 . https://doi.org/10.1161/STROKEAHA.120.029474
Centre for Clinical Brain Sciences, University of Edinburgh 2021, ' Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage: a randomised, open-label, assessor-blinded, pilot phase, non-inferiority trial ', The Lancet Neurology . https://doi.org/10.1016/S1474-4422(21)00264-7
BASE-Bielefeld Academic Search Engine Al-Shahi Salman, R, Minks, D P, Mitra, D, Rodrigues, M A, Bhatnagar, P, du Plessis, J C, Joshi, Y, Dennis, M S, Murray, G D, Newby, D E, Sandercock, P A G, Sprigg, N, Stephen, J, Sudlow, C L M, Werring, D J, Whiteley, W N, Wardlaw, J M, White, P M 2019, ' Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases : Subgroup analyses of the RESTART randomised, open-label trial ', Lancet Neurology, vol. 18, no. 7, pp. 643-652 . https://doi.org/10.1016/S1474-4422(19)30184-X The Lancet Neurology, 18(7), 643. Lancet Publishing Group RESTART collaboration & Njoku, K 2019, ' Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases : subgroup analyses of the RESTART randomised, open-label trial ', The Lancet. Neurology, vol. 18, no. 7, pp. 643-652 . https://doi.org/10.1016/S1474-4422(19)30184-X